CompletedNot Applicable

The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases

Russia150 participantsStarted 2020-10-15

Plain-language summary

The aim of the study is to assess the role of statins and different dosage regimens in the prevention of contrast-induced acute kidney injury in patients with cardiovascular diseases requiring intravenous contrast media administration before computer tomography

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Written informed consent * Indications for computer tomography with intravenous contrast media administration * Cardiovascular diseases (arterial hypertension, arrhythmia etc) Exclusion Criteria: * Pregnancy * Statin therapy before inclusion in the study * Acute coronary syndromes * Contraindications for statins administration * Patients with chronic kidney disease stages 4-5 * Contraindications for computer tomography with contrast media administration * Nephrotoxic drugs use (NSAIDS, vancomycin etc)

What they're measuring

Contrast-induced acute kidney injury

Timeframe: 48-72 hours after contrast media administration

Trial details

NCT IDNCT04666389

SponsorI.M. Sechenov First Moscow State Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Contrast-induced Acute Kidney Injury trials